Advertisement
U.S. markets closed

Fate Therapeutics, Inc. (FATE)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
6.96+0.08 (+1.16%)
At close: 04:00PM EST
7.00 +0.04 (+0.57%)
After hours: 08:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
MACD

MACD

Previous Close6.88
Open6.86
Bid6.95 x 1400
Ask7.55 x 900
Day's Range6.75 - 7.11
52 Week Range1.63 - 7.74
Volume1,507,544
Avg. Volume2,565,860
Market Cap686.27M
Beta (5Y Monthly)1.65
PE Ratio (TTM)N/A
EPS (TTM)-1.77
Earnings DateFeb 26, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est6.34
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for FATE

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Fate Therapeutics, Inc.
    Daily – Vickers Top Buyers & Sellers for 01/17/2023The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    last yearArgus Research
View more